ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 97 filers reported holding ALBIREO PHARMA INC in Q4 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $303,793 | +46.1% | 14,058 | +30.8% | 0.00% | +50.0% |
Q3 2022 | $208,000 | -10.0% | 10,748 | -7.4% | 0.00% | 0.0% |
Q2 2022 | $231,000 | -61.1% | 11,612 | -41.6% | 0.00% | -66.7% |
Q1 2022 | $594,000 | +14.2% | 19,900 | -10.8% | 0.01% | 0.0% |
Q4 2021 | $520,000 | -29.3% | 22,307 | -5.5% | 0.01% | -14.3% |
Q3 2021 | $736,000 | -17.2% | 23,595 | -6.6% | 0.01% | -12.5% |
Q2 2021 | $889,000 | -27.1% | 25,275 | -26.9% | 0.01% | -33.3% |
Q1 2021 | $1,219,000 | -5.4% | 34,581 | +0.7% | 0.01% | -20.0% |
Q4 2020 | $1,288,000 | +59.4% | 34,325 | +41.8% | 0.02% | +25.0% |
Q3 2020 | $808,000 | +49.4% | 24,215 | +18.5% | 0.01% | +71.4% |
Q2 2020 | $541,000 | +24.7% | 20,432 | -23.0% | 0.01% | 0.0% |
Q1 2020 | $434,000 | -33.7% | 26,527 | +3.0% | 0.01% | +40.0% |
Q4 2019 | $655,000 | +29.2% | 25,756 | +1.6% | 0.01% | +25.0% |
Q3 2019 | $507,000 | -37.6% | 25,338 | +0.6% | 0.00% | -33.3% |
Q2 2019 | $812,000 | -12.8% | 25,190 | -12.9% | 0.01% | -14.3% |
Q1 2019 | $931,000 | +37.3% | 28,912 | +4.5% | 0.01% | +40.0% |
Q4 2018 | $678,000 | -2.9% | 27,659 | +30.6% | 0.01% | 0.0% |
Q3 2018 | $698,000 | +13.9% | 21,181 | +22.7% | 0.01% | +25.0% |
Q2 2018 | $613,000 | – | 17,257 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 514,082 | $11,973,000 | 7.17% |
Privium Fund Management B.V. | 379,117 | $8,959,000 | 1.78% |
Birchview Capital, LP | 113,000 | $2,632,000 | 1.70% |
Sio Capital Management, LLC | 213,913 | $4,982,000 | 1.50% |
Perceptive Advisors | 4,720,278 | $109,936,000 | 0.85% |
Chicago Capital, LLC | 849,239 | $19,779,000 | 0.74% |
APOGEM CAPITAL LLC | 38,601 | $899,000 | 0.59% |
Samsara BioCapital, LLC | 100,000 | $2,329,000 | 0.45% |
Artal Group S.A. | 600,000 | $13,974,000 | 0.38% |
RICE HALL JAMES & ASSOCIATES, LLC | 458,011 | $10,667,000 | 0.38% |